Clarafond, France

Agnés Hiver

This inventor holds 1 USPTO granted patent. Top assignee: Bracco Research Sa. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Agnés Hiver. Retrieved from https://idiyas.com/inventor/agnandeacutes-hiver

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agnès Hiver: Innovator in Biologically Active Substance Delivery

Introduction

Agnès Hiver is a notable inventor based in Clarafond, France. He has made significant contributions to the field of medical technology, particularly in the delivery of biologically active substances to targeted sites within the human body. His innovative methods have the potential to enhance the efficacy of treatments and diagnostics.

Latest Patents

Agnès Hiver holds a patent for a method titled "Delivery of biologically active substance to target sites in the body of patients." This invention focuses on a technique for administering bioactive substances to patients at specific locations within the body. The method involves creating an administrable formulation that includes liposomes filled with bioactive substances and gas-filled microspheres. By injecting this formulation into a patient's circulation and applying ultrasound pulses, the gas-filled microbodies can explode, allowing the liposomes to release their contents at the desired site. This innovative approach also includes formulations available in kit form, which comprise sterile precursor components.

Career Highlights

Agnès Hiver is associated with Bracco Research SA, where he continues to develop and refine his groundbreaking methods. His work has garnered attention for its potential applications in both therapeutic and diagnostic fields.

Collaborations

Agnès has collaborated with notable colleagues, including Michel Schneider and Feng Yan, who have contributed to his research and development efforts.

Conclusion

Agnès Hiver's innovative work in the delivery of biologically active substances represents a significant advancement in medical technology. His patented methods have the potential to improve patient outcomes through targeted treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…